top of page
Recent news
Archived news


National Center for Science (NCN) grant for novel gene expression system
Prof. dr hab. Piotr Mariusz Skowron (University of Gdansk) has received National Center for Science (NCN) grant in the amount of 2,197,200..
Jun 7, 2024


Development of prototype poly-RGD pro-regenerative drug
The DNA FACE™ concept has been successfully used to develop prototype pro-regenerative drug. The EP 3.549.947.B1 patent is a result of long.
May 8, 2024


New publication in Microbial Cell Factories
One of the leading current trends in technology is the miniaturization of devices to the microscale and nanoscale. The highly advanced...
Mar 14, 2024


Publication in the International Journal of Molecular Sciences: thermophilic bacteriophages.
Bacteriophages associated with thermophiles are gaining increased attention due to their pivotal roles...
Mar 8, 2024


Publication in the International Journal of Molecular Sciences: targeting capsular bacteria
One of current trends in medical treatment is developing targeted therapeutic interventions against capsular bacteria. The publication...
Jan 5, 2024


Zawiadomienie o rozstrzygnięciu postępowania
Zamawiający BioVentures Institute Sp. z o.o informuje, że w wyniku przeprowadzonego postępowania na usługę: Opracowanie technologii...
Aug 29, 2023


ZAPYTANIE OFERTOWE
BioVentures Institute Sp. z o.o, jako podmiot realizujący projekt współfinansowany z Europejskiego Funduszu Rozwoju Regionalnego na...
Jul 11, 2023


New publication in Critical Reviews in Microbiology
This publication is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk,...
Jun 4, 2023
Grant dla BioVentures Institute Sp. z o.o.
BioVentures Institute Sp. z o.o. otrzymała dofinansowanie w ramach programu "Granty B+R dla przedsiębiorstw"
Feb 10, 2023


New publication in Microorganisms
This publication is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk,...
Aug 3, 2022


Development of prototype PDGF pro-regenerative drug
The DNA FACE™ concept has been successfully used to develop prototype pro-regenerative drug. The PL 240667 patent is a result...
May 16, 2022


New Publication in Microbial Cell Factories
This publication is a result of long-term scientific cooperation and partnership between BioVentures Institute, University of Gdańsk,...
Jan 28, 2022


Grant from The National Centre for Research and Development
The National Centre for Research and Development grant TECHMATSTRATEG2/410747/11/NCBR/2019 (2019-2022) to the Consortium led by...
Oct 2, 2021


Bacteriophages of Thermophilic ‘Bacillus Group’Bacteria—A Review
The publication reviewing potential and used by BioVentures Institute thermophilic bacteriophages and Virus-Like-Particles (VLPs)...
Jul 2, 2021


Positive initial animal trials of the recombinant anti-SARS-CoV-2 vaccine
The vaccine has been purified, analysed using a number of techniques, including electrophoresis, LC-MS, Western blotting and was...
Jun 21, 2021


Development of a novel type of recombinant anti-SARS-CoV-2 vaccine
The DNA-FACE™ concept of construction of ‘artificial’, concatemeric protein with a vaccine functionality has been used to construct an...
Apr 2, 2021


Patent in Israel granted for DNA-FACE™
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
Mar 9, 2021


Patent in US granted for DNA-FACE™
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
Dec 31, 2020


Funds from The National Centre for Research and Development
The National Centre for Research and Development grant TECHMATSTRATEG-III/0042/2019 (2020-2023) received by the Institute...
Nov 2, 2020


Patent for EU
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
Aug 28, 2020


New publication in MethodsX international journal
Detailed laboratory protocols, concerning the patented BioVentures Institute genetic engineering and protein functional programming,...
Aug 21, 2020
Patent for China
We have been informed by Chineese Patent Office that our patent application no 201580028495.1, concerning our break-through recombinant...
Aug 5, 2020
Patent in US granted for DNA-FACE™
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
Jul 2, 2020


Scientific publication
Scientific publication in the area of industrial enzymes. A novel proteinase Onygena, an improved alternative to the ‘workhorse’ of...
Jun 24, 2020
Patent for Israel
We have been informed by Israeli Patent Office that our patent application no 248011, concerning our break-through recombinant DNA...
May 29, 2020


Patent for Japan
Our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and...
Apr 17, 2020
Patent application for India
We have been informed by Indian Patent Office that our patent application no 201647039411, concerning our break-through recombinant DNA...
Mar 20, 2020


New publication in Data in Brief international journal
More technical details, concerning the patented BioVentures Institute genetic engineering and protein functional programming,...
Dec 31, 2019


New publication in Materials Science & Engineering C
The patented BioVentures Institute genetic engineering and protein functional programming, construction and biosynthesis technology,...
Nov 13, 2019


Patent for Republic of Poland
Our break-through recombinant DNA biotechnology for the construction of new generation vaccines, biologics, biosymilars, industrial and...
Aug 3, 2018


New scientific publication
New scientific publication, defining a new bacteriophage genus TP84 virus. The paper describes monographic work on TP-84 bacteriophage...
Apr 6, 2018


Establishing CLEARWING FOUNDATION FOR BIODIVERSITY
Our company and team members are environmentally conscious. BioVentures Institute’s patented technology has a potentially high impact on...
Nov 13, 2017


ClearWing Foundation for Biodiversity
Our company and team members are environmentally conscious. BioVentures Institute patented technology has potentially high impact on the...
Jul 27, 2017


Cooperation with University of Gdansk and New England Biolabs Ltd. (USA)
BioVentures InstituteSp. z o.o. continues a long term cooperation with University of Gdansk and New England Biolabs Ltd. (USA), a world...
Jul 2, 2017
The new grant issued
The new grant STRATEGMED TARGETTELO in the amount of 19 654 385.00 PLN issued by the National Center for Research and Development was...
Jan 2, 2017
Patent application to USA, EU, Israel, Japan, China, India
BioVentures Institute Sp. z o.o. has extended the international PCT patent application no WO 2015162560 A1, covering the technology of...
Nov 2, 2016


Business relationship with Israeli companies
BioVentures Institute established business relationships with several Israeli companies, as well as with the Israeli Ministry of Regional...
Feb 8, 2016


New “molecular scissors” for DNA cleavage
Cooperation in the area of engineering of enzyme performance for biotechnology purposes between BioVentures Institute Sp. z o. o. and ...
Feb 2, 2016
Cooperation agreement with Barentzymes AS
Barentzymes AS, a Norwegian biotechnology company (part of Fluenta holding) has signed a long term cooperation agreement with BioVentures...
Oct 19, 2015


Professor Piotr Skowron received the 1st award
Professor Piotr Skowron received the 1st award granted by the Pomeranian Employers Association in the category “Primum Cooperatio” i.e....
Jun 2, 2015
New patent application
BioVentures Institute Sp. z o.o. filed an international patent application (PCT). Title of application: „A method of obtaining a...
Apr 21, 2015
Funds established
In cooperation with the University of Gdańsk, BioVentures Institute Sp. z o.o. has established funds and applied research programmes for...
Mar 2, 2015
Cooperation with the University of Gdansk
Scientists from BioVentures Institute Sp. z o.o. continue their cooperation with theUniversity of Gdansk in the area of regenerative...
Oct 2, 2014


Piotr Skowron has received professor title in biological sciences.
Piotr Skowron received the professor title in biological sciences. On July 28th, after receiving positive reviews and a decision from...
Jul 2, 2014
The cooperation in the area of gene cloning and engineering of enzymes
Cooperation in the area of gene cloning and engineering of enzymes for biotechnology applications between BioVentures Institute Sp. z...
Jan 2, 2014
SATUS Venture Capital and Jagiellonian Centre of Innovation (JCI)
BioVentures Institute Sp. z o.o. has accepted a venture capital entry by SATUS Venture Capital and Jagiellonian Centre of Innovation...
Dec 2, 2013
The scientific cooperation
The ongoing scientific cooperation between BioVentures Institute Sp. z o.o., Thermo Fisher Scientific and Department of Molecular...
Aug 2, 2013
Funds established
INVESTIN programme in cooperation with BioVentures Institute Sp. z o.o. has established two funds for advanced molecular biotechnology...
Jun 5, 2013
BioVentures Institute Sp. z o.o. received funding from the European Union (EU)
BioVentures Institute Sp. z o.o. received funding from the European Union (EU) via the National Centre for Research and Development...
Oct 2, 2012
The scientific cooperation
The scientific cooperation between BioVentures Institute Sp. z o.o., Thermo Fisher Scientific and Department of Environmental Molecular...
Apr 2, 2012
bottom of page